Rob Truckenmiller, CEO of PharmaCord, talks about the company’s role in patient services, trends he sees shaping patient access to healthcare in the U.S., and a recent patient-centric merger.
In this video, Rob Truckenmiller, CEO of PharmaCord, covers various trends from patient access to specialty medications in the U.S., including trends that are shaping manufacturer strategies. He also defines the difference between enablement and empowerment when it comes to using AI in patient services, and further shares how emerging technologies could influence the future of specialty pharma services.